Granumet - SR
Pharmaceutical Formulations Intermediates
METFORMIN HCL SUSTAINED RELEASE GRANULES FOR DIRECT COMPRESSION
METFORMIN HCL SUSTAINED RELEASE GRANULES FOR DIRECT COMPRESSION
| GRADES AVAILABLE | Strength | Tablet Weight |
| Metformin HCl sustained release granules 71.43% | 500mg | 700mg |
| Metformin HCl sustained release granules 74.62% | 500mg | 670mg |
| Metformin HCl sustained release granules 77.52% | 500mg | 645mg |
Key Features
- Save up to 24 hrs per batch in manufacturing
- Increasing productivity multiple times. (up to 4X)
- Lesser documentation as of less unit operations.
- Avoid typical problem of lump formation in Metformin API.
- Adopt very simple and easy process.
- Lesser tablet weight more patient compliance.
Applications
- Immediate-Release Tablets Ensures rapid tablet disintegration for quick therapeutic effects.
- Capsules Aids in the disintegration of powder or granules inside capsules.
- Effervescent TabletsProvides stability and quick disintegration even in effervescent formulations.
Regulatory Complaince
- USP-NF • IP